Cargando…

SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances

BACKGROUND: Glioblastoma is one of the most devastating cancer worldwide based on its locally aggressive behavior and because it cannot be cured by current therapies. Defects in alternative splicing process are frequent in cancer. Recently, we demonstrated that dysregulation of the spliceosome is di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuentes-Fayos, Antonio C., Pérez-Gómez, Jesús M., E. G-García, Miguel, Jiménez-Vacas, Juan M., Blanco-Acevedo, Cristóbal, Sánchez-Sánchez, Rafael, Solivera, Juan, Breunig, Joshua J., Gahete, Manuel D., Castaño, Justo P., Luque, Raúl M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793262/ https://www.ncbi.nlm.nih.gov/pubmed/35086552 http://dx.doi.org/10.1186/s13046-022-02241-4

Ejemplares similares

Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2020)

Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2023)

THU080 Splicing Machinery Dysregulation As A Source Of Novel Diagnostic, Prognostic And Therapeutic Targets In Craniopharyngiomas
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2023)

SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers
por: Gahete, Manuel, et al.
Publicado: (2019)

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
por: Alors-Perez, Emilia, et al.
Publicado: (2021)

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
por: López-Cánovas, Juan L., et al.
Publicado: (2023)

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)

Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2020)

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2020)

Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1
por: L‐López, Fernando, et al.
Publicado: (2017)

A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
por: Gahete, Manuel D., et al.
Publicado: (2011)

Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells
por: León-González, Antonio J., et al.
Publicado: (2021)

Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2019)

A novel human tumoroid 3D model of sustained ACTH-secreting cell cultures to study critically needed therapies for Cushing's disease
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2021)

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2017)

Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer
por: Luque, Raul M, et al.
Publicado: (2023)

Role of Endogenous Cortistatin in the Regulation of Ghrelin System Expression at Pancreatic Level under Normal and Obese Conditions
por: Chanclón, Belén, et al.
Publicado: (2013)

Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer
por: Gómez-Gómez, Enrique, et al.
Publicado: (2019)

Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas
por: Alhambra-Expósito, María R., et al.
Publicado: (2018)

Raptor Preys on mTOR Imbalance in Tuberous Sclerosis
por: Ramamurthy, Aishwarya, et al.
Publicado: (2023)

Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients
por: Luque, Raúl M., et al.
Publicado: (2017)

Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer
por: Gómez‐Gómez, Enrique, et al.
Publicado: (2018)

Obesity- and gender-dependent role of endogenous somatostatin and cortistatin in the regulation of endocrine and metabolic homeostasis in mice
por: Luque, Raúl M., et al.
Publicado: (2016)

Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode
por: Luque, Raúl M., et al.
Publicado: (2016)

Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2022)

A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1
por: Closa, Adria, et al.
Publicado: (2022)

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
por: López‐Cánovas, Juan L., et al.
Publicado: (2022)

Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study
por: del Río-Moreno, Mercedes, et al.
Publicado: (2020)

Autonomic Imbalance in Lymphoma Survivors
por: Vargas-Román, Keyla, et al.
Publicado: (2021)

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters
por: Luque, Raul M., et al.
Publicado: (2015)

Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study
por: Gahete, Manuel D., et al.
Publicado: (2018)

b → ss + − anomalies from dynamical Yukawas
por: Fuentes-Martin, Javier
Publicado: (2017)

Allyl Isothiocyanate Inhibits the Proliferation of Renal Carcinoma Cell Line GRC-1 by Inducing an Imbalance Between Bcl2 and Bax
por: Jiang, Zhongyong, et al.
Publicado: (2016)

Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling
por: Gesmundo, Iacopo, et al.
Publicado: (2021)

Errata: Vol. 66, Nos. SS-1 and SS-2
Publicado: (2017)

Draft Genome Sequences of Marine RNA Viruses SF-1, SF-2, and SF-3 Recovered from San Francisco Wastewater
por: Greninger, Alexander L., et al.
Publicado: (2015)

Adipokines (Leptin, Adiponectin, Resistin) Differentially Regulate All Hormonal Cell Types in Primary Anterior Pituitary Cell Cultures from Two Primate Species
por: Sarmento-Cabral, André, et al.
Publicado: (2017)

Obesity Alters Gene Expression for GH/IGF-I Axis in Mouse Mammary Fat Pads: Differential Role of Cortistatin and Somatostatin
por: Villa-Osaba, Alicia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7a6tv5jl01g4bs0a3kdlip7i39